• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    1/24/25 5:25:43 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email
    DEFA14A 1 qipt-20250124xdefa14a.htm DEFA14A

    ​

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549


    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934


    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

    Definitive Proxy Statement

    ☒

    Definitive Additional Materials

    ☐

    Soliciting Material Pursuant to §240.14a-12

    Quipt Home Medical Corp.

    (Name of Registrant as Specified in Its Charter)

    ​

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒

    No fee required.

    ​

    ​

    ☐

    Fee paid previously with preliminary materials.

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

    ​

    ​


    GRAPHIC

    QUIPT HOME MEDICAL CORP. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MARCH 17, 2025 This Notice is prepared under the notice-and-access rules adopted by the U.S. Securities and Exchange Commission and applicable Canadian securities commissions to deliver proxy materials to its shareholders for the above-noted meeting instead of sending you paper copies of the proxy materials. Please call Quipt Home Medical Corp. (the “Corporation”) toll free at 1 (866) 466-5355 if you have any questions about this notice. The Corporation’s annual general meeting (the “Meeting”) of shareholders (the “Shareholders”) will be held at the Hampton Inn & Suites, 975 University Parkway, Sarasota, Florida on March 17, 2025 at 10:00 a.m. (ET) for the following purposes: 1. to elect four directors to serve until the next annual meeting of shareholders. 2. to re-appoint BDO USA, P.C. as auditors of the Corporation to hold office for the fiscal year ended September 30, 2025, and authorize the board of directors of the Corporation to fix the remuneration of the auditors. This Notice presents only an overview of the more complete Meeting materials that are available to you on the Internet. We encourage you to access and review all the important information contained in the Meeting materials before voting. The Meeting materials can be viewed online at https://investorrelations.quipthomemedical.com/documents/investorrelation/circulars/2025/2025.pdf and under Quipt Home Medical Corp.’s SEDAR+ profile at www.sedarplus.ca and at http://www.sec.gov. The Meeting materials include: the Proxy Statement, the form of proxy card, and a financial statement request form. Requesting Printed Meeting Materials If you want to receive a paper or e-mail copy of the Meeting materials, you must request one. Shareholders can request that paper or email copies of the Meeting materials be sent to them at no cost to them on or before 12:00 p.m. (ET) on March 3, 2025 to facilitate timely delivery. Shareholders may make their request without charge for a paper or email copy of the Meeting materials by calling the toll free number at 1 (866) 466-5355 or by sending an email to [email protected]. Voting by Proxy Registered holders: If you are not attending the Meeting, you can submit your proxy as follows: On the Internet: Go to www.investorvote.com and follow the instructions. By Telephone: Call (866) 732-VOTE (8683) (Canada and the U.S. only) or (312) 588-4290 (outside Canada and the U.S.) and follow the prompts. By Mail: You can vote by mail by requesting a paper copy of the Meeting materials, which includes a proxy card (Please see “Requesting Printed Meeting Materials”). Sign, date and return the proxy card to Computershare Investor Services Inc. (“Computershare”) by mail at Attention: Proxy Department, 8th Floor, 100 University Avenue, Toronto, Ontario M5J 2Y1. YOU MUST USE THE 15 DIGIT CONTROL NUMBER LOCATED IN THE BOX BELOW. To be effective, a proxy must be received before 10:00 a.m. (ET) on March 13, 2025, or not later than forty-eight (48) hours (excluding Saturdays, Sundays and holidays) before any adjournment or postponement of the Meeting. Non-registered holders: If you are not attending the Meeting, use the voting information form (“VIF”) provided by your intermediary (bank, trust company or broker) and return it as early as practicable to ensure that it is transmitted on time (see the VIF for details). It must be received by your intermediary with sufficient time for them to file a proxy with Computershare not later than forty-eight (48) hours (excluding Saturdays, Sundays and holidays) prior to the time set for the Meeting or any adjournment or postponement thereof by the deadline noted above. Voting in Person: For registered holders, if you plan to attend the Meeting, you must register with Computershare when you arrive at the Meeting to have voting rights at the Meeting. For non-registered holders, if you plan to attend the Meeting, you must appoint yourself in the space provided in the VIF and register with Computershare when you arrive at the Meeting to have voting rights at the Meeting. PLEASE NOTE – THIS IS NOT A VOTABLE BALLOT. YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must vote online, by telephone or request a paper copy of the Meeting materials to receive a proxy card. Control Number: THE BOARD OF DIRECTORS OF THE CORPORATION RECOMMENDS THAT YOU VOTE FOR ALL NOMINEES IN THE ELECTION OF DIRECTORS IN PROPOSAL 1 AND FOR PROPOSAL 2. Accessing Meeting Materials

    Get the next $QIPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    SEC Filings

    View All

    SEC Form 10-Q filed by Quipt Home Medical Corp.

    10-Q - Quipt Home Medical Corp. (0001540013) (Filer)

    2/9/26 4:06:03 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)

    2/4/26 5:07:02 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)

    2/4/26 5:05:55 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement

    CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the "Circular") in connection with Quipt's upcoming special meeting (the "Meeting") of the holders (the "Shareholders") of Quipt's common shares (the "Shares") to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt's profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the "SEC") on the EDGAR we

    2/4/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2025 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2025 and are reported in U.S. Dollars under GAAP. Financial Highlights: Revenue for Q4 2025 was $68.3 million compared to $61.3 million for Q4 2024, representing an 11% increase. Sequential organic revenue growth from Q3 2025 was strong at 5%.Recurring Revenue1 for Q4 2025 was strong at 80% of total revenue, driven by the gr

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Crawford Gregory John exercised 583,500 shares at a strike of $1.11, increasing direct ownership by 21% to 3,351,196 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/15/25 7:26:34 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Director Wessel Brian Joseph was granted 183,135 shares, increasing direct ownership by 1,297% to 197,260 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:37:03 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas was granted 110,000 shares, increasing direct ownership by 175% to 173,000 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:36:22 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Financials

    Live finance-specific insights

    View All

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care